Arthroscopic Repair Of Partial Thickness Articular Side Rotator Cuff Tears Using Transtendon Versus Conversion Repair Techniques

March 10, 2025 updated by: Mohamed hussein khalil, Cairo University

This study aims to compare the functional results of patients who underwent two different arthroscopic methods for the management of articular-sided partial-thickness rotator cuff tears (PT-RCTs).

The present study aims to compare the functional results following the repair of PT-RCTs using the conversion versus the trastendon techniques

Study Overview

Detailed Description

This is a prospective randomized study carried out at a tertiary trauma center between October 2022 and June 2023. The research ethical Committee authorized this study protocol [(Institutional Review Board (IRB) number: N-383-2023)], and all participants signed an informed consent prior to joining the study. This study included 50 patients with PT-RCTs who underwent arthroscopic repair using either the conversion technique (25 patients) in group A or the transtendon technique (25 patients) in group B. The random assignment of all patients to enter either group was computerized using simple randomization.

Study Type

Interventional

Enrollment (Actual)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Cairo
      • Giza, Cairo, Egypt
        • Faculty of Medicine, Cairo University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

The inclusion criteria were:

  • Patients suffering symptomatic PT-RCTs exceeding 50% of the tendon thickness, documented by preoperative magnetic resonance imaging (MRI) and confirmed by arthroscopy intraoperative.
  • Failure of nonoperative management for at least 3 months.

The exclusion criteria were:

  • Prior shoulder surgery.
  • Severe concomitant pathologies including glenohumeral arthritis, advanced subscapularis tear, and biceps tendon rupture.
  • Associated Bankart lesion.
  • Patients with uncontrolled Diabetes mellites.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: The Conversion repair technique: Group A
arthroscopic repair of partial rotator cuff tear using the conversion technique
arthroscopic repair of partial rotator cuff tear using the conversion versus the transtendon technique
Experimental: The Transtendon repair technique: Group B
arthroscopic repair of partial rotator cuff tear using the transtendon technique
arthroscopic repair of partial rotator cuff tear using the conversion versus the transtendon technique

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
American Shoulder and Elbow Surgeons score
Time Frame: baseline, and 18 months after surgery
shoulder score, the maximum is 100, the minimum is zero, a higher score means a better outcome
baseline, and 18 months after surgery
Constant and Murley score
Time Frame: baseline, and 18 months after surgery
shoulder score, the maximum is 100, the minimum is zero, a higher score means a better outcome
baseline, and 18 months after surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Visual analogue scale
Time Frame: baseline, and 18 months after surgery
pain score, the minimum is zero, the maximum is 10, the higher score means worse outcome
baseline, and 18 months after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: mohamed H khalil, M.D, Cairo university

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 1, 2022

Primary Completion (Actual)

December 31, 2024

Study Completion (Actual)

December 31, 2024

Study Registration Dates

First Submitted

March 6, 2025

First Submitted That Met QC Criteria

March 10, 2025

First Posted (Actual)

March 25, 2025

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

March 10, 2025

Last Verified

March 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Rotator Cuff Tears

Clinical Trials on arthroscopic repair of partial rotator cuff tear using the conversion versus the transtendon technique

Subscribe